Company: LRHC
Filing Date: 2025-03-07
Form Type: DEF 14C
Source: 0001213900-25-021334
Chunk: 16

Company: La Rosa Holdings Corp.
Filing Date: 2025-03-07
Form: DEF 14C
Chunk 16
---
 approval under Nasdaq Listing Rule 5635(b).

The Majority Stockholders Consent constitutes the only stockholder
approval required under the NRS, Nasdaq’s 20% Rule, our Amended and Restated Articles of Incorporation and our Bylaws, in order
to provide the Stockholder Approval required under the Securities Purchase Agreement.

The Stockholder Approval will not become effective until the date that
is twenty (20) calendar days after this Information Statement is first mailed or otherwise delivered to holders of our Common Stock as
of the Record Date.

<div align='center'>9

2.APPROVAL OF THE REVERSE STOCK SPLIT AMENDMENT AND AUTHORIZATION TO THE BOARD OF DIRECTORS TO EFFECT THE REVERSE STOCK SPLIT AT THEIR DISCRETION</div>

The Reverse Stock Split Amendment

On February 4, 2025, our Board of Directors and Majority Stockholders granted the Board of Directors a discretionary authority within the next twelve (12) months to file the Reverse Stock Split Amendment to effectuate the Reverse Stock Split of all of our issued and outstanding shares of Common Stock at an exchange ratio ranging from one for two (1:2) to one for one hundred (1:100) (the “Split Ratio Range”). The form of the Reverse Stock Split Amendment is attached to this Information Statement as Appendix A.

Background and Reasons for the Reverse Stock Split

The Board of Directors has the authority, but not the obligation, in its sole discretion and without any further action on the part of the stockholders, to effect the Reverse Stock Split within the Split Ratio Range at any time it believes to be most advantageous to our Company and stockholders in the next 12 months. The exact ratio of the Reverse Stock Split, if effected, would be set at a whole number within the range as determined by the Board of Directors in its sole discretion. The Reverse Stock Split Amendment would not change the number of authorized shares of our Common Stock and the par value of our Common Stock would remain at $0.0001 per share. As of the date of this Information Statement, we do not have any current plans, arrangements or understandings related to the issuance of any additional shares of Common Stock that will become newly available as a result of the Reverse Stock Split.

On October 10, 2024, we received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying us that, because the closing bid price for our Common Stock listed on Nasdaq was below $